Department of Anesthesiology, Zhejiang Provincial People's Hospital, Hangzhou, 310006, China.
Department of Anesthesiology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200080, China.
Int J Surg. 2020 Jan;73:57-64. doi: 10.1016/j.ijsu.2019.10.036. Epub 2019 Nov 6.
We performed this meta-analysis to evaluate the effectiveness of transcutaneous electrical acupoint stimulation (TEAS) for preventing postoperative nausea and vomiting (PONV) after general anesthesia.
We searched PubMed, EMbase, Ovid, Web of Science for relevant randomized controlled trials (RCTs) about TEAS for the prevention of PONV, published through July 31, 2019. The primary outcome was the incidence of PONV, postoperative nausea (PON) and postoperative vomiting (POV) recorded within 24 h after surgery. Secondary outcomes included the numbers of patients needing antiemetic rescue and the incidence of postoperative adverse effects referred to general anesthesia. Data were pooled and analyzed by RevMan 5.3 software.
Fourteen RCTs (1653 participants) were included in this meta-analysis. The current results suggested that application of TEAS showed obvious superiority in lower incidence of PONV (relative risk [RR] 0.54, 95% confidence interval [CI] 0.42 to 0.68, P < 0.0001), PON (RR, 0.59, 95% CI 0.49 to 0.71, P < 0.0001), POV (RR 0.46; 95% CI, 0.33 to 0.65, P < 0.0001), lower numbers of patients needing antiemetic rescue (RR 0.56, 95% CI 0.40 to 0.78, P = 0.0005), lower incidence of dizziness (RR 0.43, 95% CI 0.31 to 0.60, P < 0.0001) and pruritus (RR 0.43, 95% CI 0.31 to 0.58, P = 0.02), compared with controlled intervention.
TEAS is a reasonable modality to incorporate into a multimodal management approach for the prevention of PONV, PON, POV and associated with lower numbers needing antiemetic rescue, lower incidence of adverse effects after general anesthesia.
我们进行了这项荟萃分析,以评估经皮穴位电刺激(TEAS)预防全麻后术后恶心和呕吐(PONV)的效果。
我们检索了 PubMed、EMbase、Ovid、Web of Science 中关于 TEAS 预防 PONV 的相关随机对照试验(RCT),检索时间截至 2019 年 7 月 31 日。主要结局为术后 24 小时内记录的 PONV、术后恶心(PON)和术后呕吐(POV)的发生率。次要结局包括需要止吐药解救的患者人数和与全身麻醉相关的术后不良反应发生率。使用 RevMan 5.3 软件进行数据合并和分析。
共有 14 项 RCT(1653 名参与者)纳入本荟萃分析。目前的结果表明,TEAS 的应用在降低 PONV 发生率方面具有明显优势(相对风险 [RR] 0.54,95%置信区间 [CI] 0.42 至 0.68,P < 0.0001)、PON(RR,0.59,95%CI 0.49 至 0.71,P < 0.0001)、POV(RR 0.46;95%CI,0.33 至 0.65,P < 0.0001)、需要止吐药解救的患者人数减少(RR 0.56,95%CI 0.40 至 0.78,P = 0.0005)、头晕发生率降低(RR 0.43,95%CI 0.31 至 0.60,P < 0.0001)和瘙痒发生率降低(RR 0.43,95%CI 0.31 至 0.58,P = 0.02)与对照组相比。
TEAS 是预防 PONV、PON、POV 及相关需要止吐药解救人数减少、全麻后不良反应发生率降低的多模式管理方法中的一种合理选择。